Event
DDL 2026
December 9 - December 11
The Drug Delivery to the Lungs conference (DDL) is the premier conference and industry exhibition which is dedicated to pulmonary and nasal drug delivery.
The focus is on providing a forum to present through podium and poster presentations recent developments in the field of inhalation therapy.
The three-day conference consists of a programme of lectures covering five session themes. Each year the DDL Committee invite a long serving respiratory health professional to deliver the commemorative DDL Lecture as a way of recognising their significant scientific accomplishments achieved in respiratory health.
Cambridge Consultants is delighted to be an event sponsor and will be exhibiting on booth 115. If you are attending or would like to participate, please come and join us:
Philip Canner
With over twenty years' experience in medical device leadership, engineering, and management consultancy, Philip has led the development of an extensive range of medical technologies, with a particular focus on drug delivery.
Charlie Dean
Charlie is the Head of Sustainable Medical Technology with expertise in mechanical design and analytical methods in medical device development. He is a LCA practitioner who leads evaluation and design of medical products to drive environmental impact mitigation activities and for the circular economy.
Adam Tozer
Adam has over 10 years of experience helping organisations understand how emerging technologies can address unmet clinical needs and create differentiated healthcare solutions.
John Hainsworth
John has over twenty years’ experience leading development of advanced DPIs and MDIs, delivering novel aerodynamic, mechanical and electromechanical designs, and providing deep technical leadership in creating next‑generation drug delivery systems.